Cold Pain Therapy Market Share, Size, Trends, Industry Analysis Report, By Product (OTC Products and Prescription Products); By Application; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030

Cold Pain Therapy Market Share, Size, Trends, Industry Analysis Report, By Product (OTC Products and Prescription Products); By Application; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030

The global cold pain therapy market size is expected to reach USD 2.67 billion by 2030, according to a new study by Polaris Market Research. The report “Cold Pain Therapy Market Share, Size, Trends, Industry Analysis Report, By Product (OTC Products and Prescription Products); By Application; By Distribution Channel; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing geriatric population, the growing number of people suffering from traumatic injuries, and the rise in awareness regarding innovative and advanced cold pain therapy products are key factors expected to boost the demand and growth of the global market at a significant growth rate over the forecast period.

Moreover, the introduction of several products specially designed for injuries related to sports by key market players is also propelling the adoption and expansion of the global market over the coming years.

For instance, according to our findings, in India, the number of people over 60 years will double by 2050, accounting for around 19.6% of the total population. Thus, the country’s growing number of senior citizens is developing several concerns related to their health. Hence, the demand for cold pain therapy among the geriatric population and the adoption of advanced therapy technologies is anticipated to grow much higher in the near future.

Increasing non-fatal injury cases and growing awareness regarding healthy and fit lifestyles, coupled with the rising penetration of and prevalence of road accidents, are likely to impact the global market positively in the coming years. Additionally, various advantages offered by topical analgesics, like systematic absorption, minimized risk of toxicity, and reduced side effects, have paved the way for lucrative growth opportunities shortly.

Cold Pain Therapy Market Report Highlights

OTC products segment held the largest revenue share in 2021 owing to the easy accessibility of these products in both online and offline stores and high affordability of several relief products.

Orthopedic conditions accounted for a major global revenue share, mainly attributed to the rising prevalence of orthopedic diseases such as arthritis, joint disorders, and musculoskeletal disorders across the globe.

Retail pharmacy sector held a substantial revenue share in 2021 due to the growing number of retail stores and the wide availability of topical products in retail pharmacies in developed and developing nations.

Asia Pacific is expected to grow significantly during the forecast period because of the increasing investment in the development of healthcare infrastructure and growing technological advancements in many developing countries, including India and China.

The global players include Hisamitsu Pharmaceutical, Medline Industries, Polar Products, Romson Group of Industries, Hot and Cold Company, Medtronic, 3M Company, ROHTO Pharmaceutical, Bruder Healthcare, Medichill UK, Rapid Aid, and Johnson & Johnson.

Polaris Market Research has segmented the cold pain therapy market report based on product, application, distribution channel, and region:

Cold Pain Therapy, Product Outlook (Revenue – USD Billion, 2018 – 2030)

OTC Products

Prescription Products

Cold Pain Therapy, Application Outlook (Revenue – USD Billion, 2018 – 2030)

Orthopedic Conditions

Post-operative Therapy

Sports Medicine

Post-trauma Therapy

Cold Pain Therapy, Distribution Channel Outlook (Revenue – USD Billion, 2018 – 2030)

Hospital Pharmacy

Retail Pharmacy

E-Commerce

Cold Pain Therapy, Regional Outlook (Revenue – USD Billion, 2018 – 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa